Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

CI Financial ( TSX: CIX:CA) ( OTCPK:CIXXF) received an interim order from the Ontario Superior Court of Justice that ...

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

On Wednesday, New York-headquartered Focus Financial Partners announced plans to make Cardinal Point, which it acquired in ...

New U.S. Senator Jim Justice has earned a reputation for dodging fines, ignoring court orders, breaking contracts, and paying ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

CI Financial receives an interim court order concerning the transaction under which CI shares will be acquired by an affiliate of Mubadala Capital.

The deal counter is buzzing with new funding rounds across sectors. This and more in todays ETtech Morning Dispatch.

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing ...

“Tenvie was purpose-built to apply deep biological and chemical insights to address critical disease pathways,” said Paul L. Berns, Managing Director at ARCH Venture Partners and Executive Chair of ...

U.S. law firm Skadden, Arps, Slate, Meagher & Flom on Thursday said it has opened an office in Abu Dhabi, following other ...